Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -

Європейський Союз - словацька - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. použitie tejto vakcíny by mali byť v súlade s oficiálne odporúčania.

Європейський Союз - словацька - EMA (European Medicines Agency)

laboratoire hra pharma - ulipristal - antikoncepcia, postcoital - pohlavné hormóny a modulátory z genitálny systém , núdzovej antikoncepcie - núdzová antikoncepcia do 120 hodín (päť dní) nechráneného pohlavného styku alebo poruchy antikoncepcie.

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

egis pharmaceuticals plc, maďarsko - ulipristal - 17 - anticoncipientia